Biotech Values

[gym gravity]

If a milestone triggers, the pr should be good for a stock price that would allow financing at a much less dilutive price though.

They could play patient and cool though and hold out for a big HCV partner.

In Dew's recent conversation of valuation I wanted to ask what he thought of IDIX near $10 in 2008.

They probably had a little more cash at that time than they do now, pre-GSK partnership, and pipeline was much earlier in development.

My point would be that Those Who Bought it up to $10 should be at least as interested in taking it to double digits again.